首页 > 最新文献

Federal practitioner : for the health care professionals of the VA, DoD, and PHS最新文献

英文 中文
Insights Into Veterans' Motivations and Hesitancies for COVID-19 Vaccine Uptake: A Mixed-Methods Analysis. 洞察退伍军人对COVID-19疫苗接种的动机和犹豫:一项混合方法分析。
Pub Date : 2025-08-01 Epub Date: 2025-08-17 DOI: 10.12788/fp.0602
Alexis K Barrett, Jaime E Sidani, Kelly H Burkitt, Elijah Z Lovelace, Ali F Sonel, Beth L Hoffman, Galen Switzer, Keri L Rodriguez, Kristina L Hruska, Maria K Mor, Nicole M Beyer, Riley Wolynn, Tiffany Pellathy, Michael J Fine

Background: Despite the morbidity and mortality associated with COVID-19 infection, vaccine hesitancy remains a barrier to uptake. This article assessed whether unique clusters can be identified based on COVID-19-related thoughts and feelings and whether cluster membership is associated with COVID-19 vaccination. We also explored how individuals' thoughts, beliefs, and trust shape motivations and hesitancies for vaccine use.

Methods: This mixed-methods quality improvement project was conducted from July 2021 through May 2022 in Primary Care at the Veterans Affairs Pittsburgh Healthcare System. The primary outcome was self-reported COVID-19 vaccination. K-means analysis were used to identify clusters based on questionnaire responses, and multivariable logistic regression were used to assess the association between cluster membership and vaccination. We conducted qualitative interviews with patients in the 2 clusters with the lowest vaccination rates to explore vaccination motivations and hesitancies.

Results: Among 1208 respondents, 1034 (85.6%) were vaccinated. Four unique clusters were identified with vaccination rates of 29.9%, 93.3%, 93.5%, and 98.9%. Cluster membership was independently associated with vaccination, with adjusted odds ratios in the 3 most frequently vaccinated clusters of 12.1 (95% CI, 6.1-23.8), 13.0 (95% CI, 6.9-24.5), and 48.6 (95% CI, 15.5-152.0). Thematic analyses of 47 qualitative interviews found that protecting oneself and protecting others were the most common motivators for vaccination. The most common concerns were the rapid development of the vaccines and adverse effects, both more frequently endorsed in the cluster with the lowest vaccination rate.

Conclusions: Unique patient clusters based on infection- and vaccine-related thoughts and feelings are independently associated with COVID-19 vaccination. Identifiable themes regarding vaccine uptake and hesitancy vary among these clusters. These themes can be used to tailor strategies to diminish vaccine hesitancy and augment vaccination uptake among veterans.

背景:尽管发病率和死亡率与COVID-19感染相关,但疫苗犹豫仍然是接种的障碍。本文评估了是否可以根据与COVID-19相关的思想和感受识别出独特的集群,以及集群成员是否与COVID-19疫苗接种相关。我们还探讨了个人的思想、信仰和信任如何影响疫苗使用的动机和犹豫。方法:该混合方法质量改进项目于2021年7月至2022年5月在匹兹堡退伍军人事务部医疗保健系统的初级保健部门进行。主要终点是自我报告的COVID-19疫苗接种。k -均值分析用于根据问卷回答识别聚类,多变量逻辑回归用于评估聚类隶属度与疫苗接种之间的关系。我们对疫苗接种率最低的两组患者进行了定性访谈,以探讨疫苗接种动机和犹豫。结果:1208名应答者中,1034名(85.6%)接种了疫苗。疫苗接种率分别为29.9%、93.3%、93.5%和98.9%。聚类隶属度与疫苗接种独立相关,3个最常接种疫苗的聚类的调整优势比为12.1 (95% CI, 6.1-23.8)、13.0 (95% CI, 6.9-24.5)和48.6 (95% CI, 15.5-152.0)。对47个定性访谈的专题分析发现,保护自己和保护他人是接种疫苗的最常见动机。最常见的关切是疫苗的迅速发展和不良影响,这两者在疫苗接种率最低的集群中更经常得到认可。结论:基于感染和疫苗相关思想和感受的独特患者群与COVID-19疫苗接种独立相关。关于疫苗接种和犹豫的可识别主题在这些群集中各不相同。这些主题可用于制定战略,以减少疫苗犹豫并增加退伍军人的疫苗接种率。
{"title":"Insights Into Veterans' Motivations and Hesitancies for COVID-19 Vaccine Uptake: A Mixed-Methods Analysis.","authors":"Alexis K Barrett, Jaime E Sidani, Kelly H Burkitt, Elijah Z Lovelace, Ali F Sonel, Beth L Hoffman, Galen Switzer, Keri L Rodriguez, Kristina L Hruska, Maria K Mor, Nicole M Beyer, Riley Wolynn, Tiffany Pellathy, Michael J Fine","doi":"10.12788/fp.0602","DOIUrl":"10.12788/fp.0602","url":null,"abstract":"<p><strong>Background: </strong>Despite the morbidity and mortality associated with COVID-19 infection, vaccine hesitancy remains a barrier to uptake. This article assessed whether unique clusters can be identified based on COVID-19-related thoughts and feelings and whether cluster membership is associated with COVID-19 vaccination. We also explored how individuals' thoughts, beliefs, and trust shape motivations and hesitancies for vaccine use.</p><p><strong>Methods: </strong>This mixed-methods quality improvement project was conducted from July 2021 through May 2022 in Primary Care at the Veterans Affairs Pittsburgh Healthcare System. The primary outcome was self-reported COVID-19 vaccination. K-means analysis were used to identify clusters based on questionnaire responses, and multivariable logistic regression were used to assess the association between cluster membership and vaccination. We conducted qualitative interviews with patients in the 2 clusters with the lowest vaccination rates to explore vaccination motivations and hesitancies.</p><p><strong>Results: </strong>Among 1208 respondents, 1034 (85.6%) were vaccinated. Four unique clusters were identified with vaccination rates of 29.9%, 93.3%, 93.5%, and 98.9%. Cluster membership was independently associated with vaccination, with adjusted odds ratios in the 3 most frequently vaccinated clusters of 12.1 (95% CI, 6.1-23.8), 13.0 (95% CI, 6.9-24.5), and 48.6 (95% CI, 15.5-152.0). Thematic analyses of 47 qualitative interviews found that protecting oneself and protecting others were the most common motivators for vaccination. The most common concerns were the rapid development of the vaccines and adverse effects, both more frequently endorsed in the cluster with the lowest vaccination rate.</p><p><strong>Conclusions: </strong>Unique patient clusters based on infection- and vaccine-related thoughts and feelings are independently associated with COVID-19 vaccination. Identifiable themes regarding vaccine uptake and hesitancy vary among these clusters. These themes can be used to tailor strategies to diminish vaccine hesitancy and augment vaccination uptake among veterans.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"292-303g"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proactive Penicillin Allergy Delabeling: Lessons Learned From a Quality Improvement Project. 主动青霉素过敏去标签:从质量改进项目中吸取的教训。
Pub Date : 2025-08-01 Epub Date: 2025-08-17 DOI: 10.12788/fp.0611
Maj Sarah McDonald, Derek Smith

Background: About 9% of all patients have a health record indicating penicillin allergy, but only 10% of these patients are truly allergic on confirmatory testing. This high percentage of incorrect labeling creates a burden for the health care system and patients, making the removal of this diagnosis an important priority. Until recently, penicillin delabeling has been done primarily by allergists, but integration with primary care is needed.

Observations: A program was developed that successfully trained primary care practitioners (PCPs) to use the PEN-FAST clinical criteria to identify low-risk patients and conduct an oral test for allergy. This model allows low-risk patients to undergo testing in a primary care office with resources available to treat any immunoglobulin E mediated severe reaction. Patients who test negative for a penicillin allergy can then be delabeled and receive more appropriate antibiotics during future infections. Skin testing was only used in 18% of the tested population and 94% of tested patients tolerated the antibiotic and their penicillin allergy history was delabeled.

Conclusions: In this program most penicillin allergy labels were cleared based on clinical criteria and oral challenge alone, highlighting the potential benefits of PEN-FAST. Expansion of training should be offered to PCPs to conduct oral challenges in appropriate settings in an effort to reduce this significant burden on patient care.

背景:约9%的患者有青霉素过敏的健康记录,但这些患者中只有10%在确证试验中确实过敏。如此高比例的不正确标签给卫生保健系统和患者造成了负担,使消除这种诊断成为一项重要的优先事项。直到最近,青霉素去标签主要是由过敏症专家完成的,但需要与初级保健相结合。观察:开发了一个项目,成功地培训初级保健从业人员(pcp)使用PEN-FAST临床标准来识别低风险患者并进行口腔过敏测试。这种模式允许低风险患者在有资源的初级保健办公室接受检测,以治疗任何免疫球蛋白E介导的严重反应。对青霉素过敏检测呈阴性的患者可以取消标签,并在未来感染时接受更适当的抗生素治疗。皮肤试验仅在18%的测试人群中使用,94%的测试患者耐受抗生素,他们的青霉素过敏史被删除。结论:在这个项目中,大多数青霉素过敏标签都是基于临床标准和口服刺激而清除的,这突出了PEN-FAST的潜在益处。应向pcp提供扩大培训,以便在适当的环境中进行口腔挑战,以努力减轻患者护理的这一重大负担。
{"title":"Proactive Penicillin Allergy Delabeling: Lessons Learned From a Quality Improvement Project.","authors":"Maj Sarah McDonald, Derek Smith","doi":"10.12788/fp.0611","DOIUrl":"10.12788/fp.0611","url":null,"abstract":"<p><strong>Background: </strong>About 9% of all patients have a health record indicating penicillin allergy, but only 10% of these patients are truly allergic on confirmatory testing. This high percentage of incorrect labeling creates a burden for the health care system and patients, making the removal of this diagnosis an important priority. Until recently, penicillin delabeling has been done primarily by allergists, but integration with primary care is needed.</p><p><strong>Observations: </strong>A program was developed that successfully trained primary care practitioners (PCPs) to use the PEN-FAST clinical criteria to identify low-risk patients and conduct an oral test for allergy. This model allows low-risk patients to undergo testing in a primary care office with resources available to treat any immunoglobulin E mediated severe reaction. Patients who test negative for a penicillin allergy can then be delabeled and receive more appropriate antibiotics during future infections. Skin testing was only used in 18% of the tested population and 94% of tested patients tolerated the antibiotic and their penicillin allergy history was delabeled.</p><p><strong>Conclusions: </strong>In this program most penicillin allergy labels were cleared based on clinical criteria and oral challenge alone, highlighting the potential benefits of PEN-FAST. Expansion of training should be offered to PCPs to conduct oral challenges in appropriate settings in an effort to reduce this significant burden on patient care.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"308-313a"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Military Imposters: What Drives Them and How They Damage Us All. 军事骗子:是什么驱使他们以及他们如何伤害我们所有人。
Pub Date : 2025-08-01 Epub Date: 2025-08-14 DOI: 10.12788/fp.0616
Cynthia M A Geppert
{"title":"Military Imposters: What Drives Them and How They Damage Us All.","authors":"Cynthia M A Geppert","doi":"10.12788/fp.0616","DOIUrl":"10.12788/fp.0616","url":null,"abstract":"","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"290-291"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Intrathoracic Manifestations of Metastatic Prostate Cancer: A Case Series. 转移性前列腺癌的不典型胸内表现:一个病例系列。
Pub Date : 2025-08-01 Epub Date: 2025-08-15 DOI: 10.12788/fp.0606
Iman Makki, Neda Valizadeh, David K Lee, Mohammad Al-Ajam

Background: Prostate cancer frequently metastasizes to bone and regional lymph nodes, but atypical intrathoracic presentation can occur.

Case presentation: Three cases of atypical intrathoracic manifestations of metastatic prostate cancer highlight the need to consider prostate cancer in the differential diagnosis of intrathoracic lesions, even in the absence of typical bony metastases. One case involved pleural metastatic deposits with associated malignant effusion. A second patient experienced isolated endobronchial lesions that led to obstruction. The third patient had isolated pulmonary nodules without associated bone disease years after prostatectomy. We review prevalence, diagnosis, and management issues related to these unusual prostate cancer scenarios.

Conclusions: These atypical metastatic manifestations of prostate cancer present diagnostic conundrums that may potentially delay timely diagnosis and appropriate management. A high index of suspicion, appropriate imaging, and judicious use of immunohistochemistry are paramount to ensure these atypical manifestations are identified.

背景:前列腺癌经常转移到骨和局部淋巴结,但也可能发生不典型的胸内表现。病例介绍:三例转移性前列腺癌的非典型胸内表现突出了在胸内病变的鉴别诊断中考虑前列腺癌的必要性,即使没有典型的骨转移。一例胸膜转移性沉积伴恶性积液。第二例患者出现孤立的支气管内病变导致梗阻。第三例患者在前列腺切除术后几年有孤立的肺结节,没有相关的骨疾病。我们回顾患病率,诊断和管理问题相关的这些不寻常的前列腺癌的情况。结论:这些前列腺癌的非典型转移表现存在诊断难题,可能会延迟及时诊断和适当治疗。高度的怀疑,适当的影像学检查和免疫组织化学的明智使用是确保这些非典型表现被识别的关键。
{"title":"Atypical Intrathoracic Manifestations of Metastatic Prostate Cancer: A Case Series.","authors":"Iman Makki, Neda Valizadeh, David K Lee, Mohammad Al-Ajam","doi":"10.12788/fp.0606","DOIUrl":"10.12788/fp.0606","url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer frequently metastasizes to bone and regional lymph nodes, but atypical intrathoracic presentation can occur.</p><p><strong>Case presentation: </strong>Three cases of atypical intrathoracic manifestations of metastatic prostate cancer highlight the need to consider prostate cancer in the differential diagnosis of intrathoracic lesions, even in the absence of typical bony metastases. One case involved pleural metastatic deposits with associated malignant effusion. A second patient experienced isolated endobronchial lesions that led to obstruction. The third patient had isolated pulmonary nodules without associated bone disease years after prostatectomy. We review prevalence, diagnosis, and management issues related to these unusual prostate cancer scenarios.</p><p><strong>Conclusions: </strong>These atypical metastatic manifestations of prostate cancer present diagnostic conundrums that may potentially delay timely diagnosis and appropriate management. A high index of suspicion, appropriate imaging, and judicious use of immunohistochemistry are paramount to ensure these atypical manifestations are identified.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 Suppl3","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations Between Prescreening Dietary Patterns and Longitudinal Colonoscopy Outcomes in Veterans. 退伍军人预先筛查饮食模式与纵向结肠镜检查结果之间的关系。
Pub Date : 2025-08-01 Epub Date: 2025-08-15 DOI: 10.12788/fp.0609
April R Williams, Thomas S Redding, Brian A Sullivan, Xuejun Qin, Belinda Ear, Kellie J Sims, Elizabeth R Hauser, Christina D Williams, Jason A Dominitz, David Lieberman

Background: Understanding associations between diet and long-term risk for colorectal cancer (CRC) among US veterans may provide insight for patient-clinician decisions about lifestyle recommendations as part of a CRC screening program.

Methods: Asymptomatic US veterans aged 50 to 75 years who received screening colonoscopy between 1994 and 1997 were followed through 2009. The most significant colonoscopy findings (MSCFs) across the study period were classified as no neoplasia, not advanced adenomas, or advanced neoplasia (AN). The food frequency questionnaire was used to calculate raw and percent scores for the Healthy Eating Index (HEI), Mediterranean diet (MD), and Dietary Approaches to Stop Hypertension (DASH) dietary patterns. In cross-sectional analyses, multinomial logistic regression models tested for associations between dietary pattern scores and MSCF, controlling for demographics.

Results: Among 3023 participants with complete data, 96.7% were male, and 83.8% were non-Hispanic White. Higher dietary patterns scores (ie, healthier diet) had similar or lower adjusted odds ratios (aORs) for AN vs no neoplasia (HEI: aOR, 1.00 [95% CI, 0.99-1.01]; MD: aOR, 0.95 [95% CI, 0.90-1.00]; DASH: aOR, 0.99 [95% CI, 0.98-1.00]). Higher grain category scores generally had lower aORs for AN for each dietary pattern (HEI: aOR, 0.96 [95% CI, 0.93-0.99]; MD: aOR, 0.29 [95% CI, 0.14-0.62]; DASH: aOR, 0.86 [95% CI, 0.78-0.95]).

Conclusions: Healthy dietary patterns were associated with lower aORs for colonic neoplasia among veterans enrolled in a CRC screening program. More research is needed to determine the role of dietary assessments for tailored CRC prevention and surveillance.

背景:了解美国退伍军人饮食与结直肠癌(CRC)长期风险之间的关系,可能为作为结直肠癌筛查项目一部分的生活方式建议的患者-临床决策提供见解。方法:对1994年至1997年间接受结肠镜筛查的50至75岁无症状美国退伍军人进行随访至2009年。在整个研究期间,最显著的结肠镜检查结果(MSCFs)被分类为无瘤变、非晚期腺瘤或晚期瘤变(AN)。食物频率问卷用于计算健康饮食指数(HEI)、地中海饮食(MD)和预防高血压的饮食方法(DASH)饮食模式的原始分数和百分比。在横断面分析中,多项逻辑回归模型检验了饮食模式评分和MSCF之间的关系,控制了人口统计学因素。结果:在3023名数据完整的参与者中,96.7%为男性,83.8%为非西班牙裔白人。较高的饮食模式评分(即更健康的饮食)与无肿瘤的校正比值比(aOR)相似或更低(HEI: aOR, 1.00 [95% CI, 0.99-1.01]; MD: aOR, 0.95 [95% CI, 0.90-1.00]; DASH: aOR, 0.99 [95% CI, 0.98-1.00])。籽粒分类得分越高,每种膳食模式中AN的aOR越低(HEI: aOR, 0.96 [95% CI, 0.93-0.99]; MD: aOR, 0.29 [95% CI, 0.14-0.62]; DASH: aOR, 0.86 [95% CI, 0.78-0.95])。结论:在参加结直肠癌筛查项目的退伍军人中,健康的饮食模式与较低的结肠肿瘤aORs相关。需要更多的研究来确定饮食评估在CRC预防和监测中的作用。
{"title":"Associations Between Prescreening Dietary Patterns and Longitudinal Colonoscopy Outcomes in Veterans.","authors":"April R Williams, Thomas S Redding, Brian A Sullivan, Xuejun Qin, Belinda Ear, Kellie J Sims, Elizabeth R Hauser, Christina D Williams, Jason A Dominitz, David Lieberman","doi":"10.12788/fp.0609","DOIUrl":"10.12788/fp.0609","url":null,"abstract":"<p><strong>Background: </strong>Understanding associations between diet and long-term risk for colorectal cancer (CRC) among US veterans may provide insight for patient-clinician decisions about lifestyle recommendations as part of a CRC screening program.</p><p><strong>Methods: </strong>Asymptomatic US veterans aged 50 to 75 years who received screening colonoscopy between 1994 and 1997 were followed through 2009. The most significant colonoscopy findings (MSCFs) across the study period were classified as no neoplasia, not advanced adenomas, or advanced neoplasia (AN). The food frequency questionnaire was used to calculate raw and percent scores for the Healthy Eating Index (HEI), Mediterranean diet (MD), and Dietary Approaches to Stop Hypertension (DASH) dietary patterns. In cross-sectional analyses, multinomial logistic regression models tested for associations between dietary pattern scores and MSCF, controlling for demographics.</p><p><strong>Results: </strong>Among 3023 participants with complete data, 96.7% were male, and 83.8% were non-Hispanic White. Higher dietary patterns scores (ie, healthier diet) had similar or lower adjusted odds ratios (aORs) for AN vs no neoplasia (HEI: aOR, 1.00 [95% CI, 0.99-1.01]; MD: aOR, 0.95 [95% CI, 0.90-1.00]; DASH: aOR, 0.99 [95% CI, 0.98-1.00]). Higher grain category scores generally had lower aORs for AN for each dietary pattern (HEI: aOR, 0.96 [95% CI, 0.93-0.99]; MD: aOR, 0.29 [95% CI, 0.14-0.62]; DASH: aOR, 0.86 [95% CI, 0.78-0.95]).</p><p><strong>Conclusions: </strong>Healthy dietary patterns were associated with lower aORs for colonic neoplasia among veterans enrolled in a CRC screening program. More research is needed to determine the role of dietary assessments for tailored CRC prevention and surveillance.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 Suppl3","pages":"S30-S39"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Impact of Antidepressants on Cancer Treatment: A Retrospective Analysis of 14 Antineoplastic Agents. 评估抗抑郁药对癌症治疗的影响:14种抗肿瘤药物的回顾性分析。
Pub Date : 2025-08-01 Epub Date: 2025-08-18 DOI: 10.12788/fp.0586
Thu-Lan T Luong, Brian J Reinhardt, Karen J Shou, Oskar F Kigelman, Kimberly M Greenfield, Eric F Torres Gutierrez, Michael K Zamani

Background: Rates of depression among patients with cancer have increased, illustrating the importance of mental health care during treatment. This study sought to identify antidepressants with boxed warnings for increased suicidal risk and known to have drug-drug interactions.

Methods: This retrospective analysis used the US Department of Defense Cancer Registry, Comprehensive Ambulatory/Professional Encounter Record, and Pharmacy Data Transaction Service databases. Patients with cancer were identified, and data collected included patient diagnoses and dispensed medications. Medications were divided into groups based on the pharmacy database therapeutic codes.

Results: This analysis identified 2210 patients with 2104 documented diagnoses, 2113 recorded prescriptions treated with 14 antineoplastic agents. Breast, lung, testicular, endometrial, and ovarian were the most common cancers among the 51 types treated. Of the 2113 patients with recorded prescriptions, 1297 patients (61.4%) received 109 cancer medications, including 96 different antineoplastics; 750 (35.5%) patients were prescribed 17 different types of antidepressants. In addition, 1089 unique prescriptions were filled (8 medications prescribed for ≥ 1000 patients). Patients who took antidepressants had more diagnosed health issues and received more prescription medications. The mean number of prescriptions dispensed in patients prescribed antidepressants vs those not prescribed antidepressants showed a significant difference (P < .05) in all groups, except anticonvulsants (P = .12) and other antipsychotics (P = .09). Although antidepressant treatment increased, there was no significant change in antidepressants prescribed annually (mean [SD] 23% [5%]).

Conclusions: The study provides a comprehensive overview of noncancer medication use in the Military Health System during systemic cancer treatment, specifically the use of antidepressants from 2003 to 2022, and highlights potential drug interactions that may affect treatment outcomes. Future research should prioritize the analysis of drug-drug interactions between cancer and noncancer drugs with antidepressants.

背景:癌症患者的抑郁率有所增加,说明了治疗过程中心理健康护理的重要性。这项研究试图识别带有黑框警告的抗抑郁药物,这些药物会增加自杀风险,并且已知会产生药物相互作用。方法:回顾性分析使用了美国国防部癌症登记处、综合门诊/专业就诊记录和药房数据交易服务数据库。确定癌症患者,收集的数据包括患者诊断和分配的药物。根据药学数据库的治疗代码对药物进行分组。结果:该分析确定了2210例患者,记录了2104例诊断,2113例记录了14种抗肿瘤药物的处方。在接受治疗的51种癌症中,乳腺癌、肺癌、睾丸癌、子宫内膜癌和卵巢癌是最常见的。在记录处方的2113例患者中,1297例(61.4%)患者接受了109种癌症药物治疗,包括96种不同的抗肿瘤药物;750例(35.5%)患者服用了17种不同类型的抗抑郁药。此外,填写了1089个独特处方(8种药物处方≥1000例患者)。服用抗抑郁药的患者诊断出的健康问题更多,接受的处方药也更多。除抗惊厥药(P = 0.12)和其他抗精神病药(P = 0.09)外,各组患者抗抑郁药与非抗抑郁药的平均处方数差异均有统计学意义(P < 0.05)。虽然抗抑郁药物治疗增加,但每年服用抗抑郁药物的数量没有显著变化(平均[SD] 23%[5%])。结论:该研究全面概述了2003年至2022年军事卫生系统在系统性癌症治疗期间非癌症药物的使用情况,特别是抗抑郁药的使用情况,并强调了可能影响治疗结果的潜在药物相互作用。未来的研究应优先分析癌症和非癌症药物与抗抑郁药之间的药物相互作用。
{"title":"Assessing the Impact of Antidepressants on Cancer Treatment: A Retrospective Analysis of 14 Antineoplastic Agents.","authors":"Thu-Lan T Luong, Brian J Reinhardt, Karen J Shou, Oskar F Kigelman, Kimberly M Greenfield, Eric F Torres Gutierrez, Michael K Zamani","doi":"10.12788/fp.0586","DOIUrl":"10.12788/fp.0586","url":null,"abstract":"<p><strong>Background: </strong>Rates of depression among patients with cancer have increased, illustrating the importance of mental health care during treatment. This study sought to identify antidepressants with boxed warnings for increased suicidal risk and known to have drug-drug interactions.</p><p><strong>Methods: </strong>This retrospective analysis used the US Department of Defense Cancer Registry, Comprehensive Ambulatory/Professional Encounter Record, and Pharmacy Data Transaction Service databases. Patients with cancer were identified, and data collected included patient diagnoses and dispensed medications. Medications were divided into groups based on the pharmacy database therapeutic codes.</p><p><strong>Results: </strong>This analysis identified 2210 patients with 2104 documented diagnoses, 2113 recorded prescriptions treated with 14 antineoplastic agents. Breast, lung, testicular, endometrial, and ovarian were the most common cancers among the 51 types treated. Of the 2113 patients with recorded prescriptions, 1297 patients (61.4%) received 109 cancer medications, including 96 different antineoplastics; 750 (35.5%) patients were prescribed 17 different types of antidepressants. In addition, 1089 unique prescriptions were filled (8 medications prescribed for ≥ 1000 patients). Patients who took antidepressants had more diagnosed health issues and received more prescription medications. The mean number of prescriptions dispensed in patients prescribed antidepressants vs those not prescribed antidepressants showed a significant difference (<i>P</i> < .05) in all groups, except anticonvulsants (<i>P</i> = .12) and other antipsychotics (<i>P</i> = .09). Although antidepressant treatment increased, there was no significant change in antidepressants prescribed annually (mean [SD] 23% [5%]).</p><p><strong>Conclusions: </strong>The study provides a comprehensive overview of noncancer medication use in the Military Health System during systemic cancer treatment, specifically the use of antidepressants from 2003 to 2022, and highlights potential drug interactions that may affect treatment outcomes. Future research should prioritize the analysis of drug-drug interactions between cancer and noncancer drugs with antidepressants.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 Suppl3","pages":"S40-S51c"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COPD CARE Academy: Design of Purposeful Training Guided by Implementation Strategies. 慢性阻塞性肺病护理学院:以实施策略为指导的有目的培训设计。
Pub Date : 2025-08-01 Epub Date: 2025-08-15 DOI: 10.12788/fp.0613
Edward C Portillo, Steven Do, Tiffany M Parham, Jordyn Kettner, Nora Jacobson, Jenna Vande Hey, Dylan Erdelt, Martha Maurer, Tim Hagen, Molly Lehmann, Sarah Will, Heather Ourth, Michelle Chui, M Shawn McFarland

Background: Clinical training content for real-world care delivery is important to promote high-quality care. Clinical training promotes knowledge acquisition and additional implementation strategies are needed to translate those acquired skills into practice-based changes.

Observations: The Chronic Obstructive Pulmonary Disease Coordinated Access to Reduce Exacerbations (COPD CARE) Academy is a training initiative implemented at ≥ 49 US Department of Veterans Affairs (VA) medical centers. The Academy provides training on the implementation of COPD CARE programs and promotes complex care transitions. The Academy offers implementation strategies for local champions to leverage VA and academic institution partnerships.

Conclusions: The COPD CARE Academy represents an interprofessional collaboration among frontline clinicians and VA leadership to design a training program using quality improvement methodology for better care for patients with COPD.

背景:临床培训内容对提高现实世界的护理质量至关重要。临床培训促进知识获取,需要额外的实施策略将获得的技能转化为基于实践的变化。观察:慢性阻塞性肺疾病协调获取以减少恶化(COPD CARE)学院是一项在美国退伍军人事务部(VA)医疗中心实施的培训计划。该学院提供COPD护理项目实施方面的培训,并促进复杂护理过渡。学院为当地冠军提供实施策略,以利用VA和学术机构的合作伙伴关系。结论:COPD CARE Academy代表了一线临床医生和VA领导之间的跨专业合作,设计了一个使用质量改进方法的培训项目,以更好地照顾COPD患者。
{"title":"COPD CARE Academy: Design of Purposeful Training Guided by Implementation Strategies.","authors":"Edward C Portillo, Steven Do, Tiffany M Parham, Jordyn Kettner, Nora Jacobson, Jenna Vande Hey, Dylan Erdelt, Martha Maurer, Tim Hagen, Molly Lehmann, Sarah Will, Heather Ourth, Michelle Chui, M Shawn McFarland","doi":"10.12788/fp.0613","DOIUrl":"10.12788/fp.0613","url":null,"abstract":"<p><strong>Background: </strong>Clinical training content for real-world care delivery is important to promote high-quality care. Clinical training promotes knowledge acquisition and additional implementation strategies are needed to translate those acquired skills into practice-based changes.</p><p><strong>Observations: </strong>The Chronic Obstructive Pulmonary Disease Coordinated Access to Reduce Exacerbations (COPD CARE) Academy is a training initiative implemented at ≥ 49 US Department of Veterans Affairs (VA) medical centers. The Academy provides training on the implementation of COPD CARE programs and promotes complex care transitions. The Academy offers implementation strategies for local champions to leverage VA and academic institution partnerships.</p><p><strong>Conclusions: </strong>The COPD CARE Academy represents an interprofessional collaboration among frontline clinicians and VA leadership to design a training program using quality improvement methodology for better care for patients with COPD.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation and Medical Oncology Perspectives on Oligometastatic Disease Treatment. 放射和医学肿瘤学在少转移性疾病治疗中的应用。
Pub Date : 2025-08-01 Epub Date: 2025-08-07 DOI: 10.12788/fp.0603
Jonathan B Wallach, Sheetal Malhotra, Steve P Lee, Lori Hoffman-Hogg, Ronald Shapiro, Gabriela Wechsler, Katherine Faricy-Anderson, Mary C McGunigal, Maria D Kelly, Ruchika Gutt

Background: Recent phase 2 randomized clinical trials support the use of aggressive local treatment in addition to systemic therapy for oligometastatic disease (OMD) to improve progression-free survival and overall survival. These studies have mostly incorporated stereotactic body radiotherapy and serve as the foundation for multiple phase 3 trials aiming to determine how many metastases comprehensive local radiotherapy (RT) offer survival benefits, and for which cancers.

Methods: To understand clinician views on the role of local RT for OMD, a 12-question survey was developed that included case examples. The survey was distributed to Veterans Health Administration (VHA) radiation oncologists and medical oncologists.

Results: Of 106 survey respondents, 59 (55.7%) were radiation oncologists and 47 (44.3%) were medical oncologists. All respondents indicated high-dose RT has potential benefits for appropriately selected cases. Most oncologists (88.7%) responded that RT for OMD contributes to cure (88.1% radiation oncologists, 89.4% medical oncologists; P = .84). More than half (52.9%) of respondents (55.2% radiation oncologists, 50.0% medical oncologists; P = .60) indicated that local RT for OMD should not be limited by histology. Most radiation oncologists classified ≤ 5 lesions as OMD, whereas most medical oncologists classified ≤ 3 lesions as OMD (P = .006). Thirty-six medical oncologists (76.6%) has a radiation oncology department at their institution. This subgroup was more likely to consider local RT as potentially curative than peers without radiation oncology at their institution (94.4% vs 72.7%; P = .04). Management differences in the 3 oligometastatic cases were also identified.

Conclusions: The results of this study highlight ongoing support among VHA oncologists for local RT in the management of OMD and reveal specialty-based and access-based variability in treatment perspectives.

背景:最近的2期随机临床试验支持在对寡转移性疾病(OMD)进行全身治疗的基础上,采用积极的局部治疗来改善无进展生存期和总生存期。这些研究大多纳入了立体定向体放疗,并作为多个3期试验的基础,旨在确定有多少转移性局部综合放疗(RT)提供生存益处,以及针对哪些癌症。方法:为了解临床医生对局部放疗在OMD中的作用的看法,我们开展了一项包括病例在内的12个问题的调查。该调查被分发给退伍军人健康管理局(VHA)的放射肿瘤学家和医学肿瘤学家。结果:106名调查对象中,放射肿瘤学家59人(55.7%),内科肿瘤学家47人(44.3%)。所有应答者都表示,高剂量放射治疗对适当选择的病例有潜在的益处。大多数肿瘤学家(88.7%)认为放射肿瘤学家(88.1%)和内科肿瘤学家(89.4%)认为放射治疗有助于治愈OMD。超过一半(52.9%)的受访者(放射肿瘤学家55.2%,内科肿瘤学家50.0%,P = 0.60)认为局部放射治疗不应受组织学限制。大多数放射肿瘤学家将≤5个病变归为OMD,而大多数内科肿瘤学家将≤3个病变归为OMD (P = 0.006)。36名肿瘤科医生(76.6%)在其所在机构设有放射肿瘤科。该亚组更有可能认为局部放疗比其所在机构未进行放射肿瘤学治疗的同龄人具有潜在的疗效(94.4% vs 72.7%; P = 0.04)。3例低转移病例的治疗差异也被确定。结论:本研究的结果突出了VHA肿瘤学家对局部RT治疗OMD的持续支持,并揭示了治疗角度基于专科和基于可及性的差异。
{"title":"Radiation and Medical Oncology Perspectives on Oligometastatic Disease Treatment.","authors":"Jonathan B Wallach, Sheetal Malhotra, Steve P Lee, Lori Hoffman-Hogg, Ronald Shapiro, Gabriela Wechsler, Katherine Faricy-Anderson, Mary C McGunigal, Maria D Kelly, Ruchika Gutt","doi":"10.12788/fp.0603","DOIUrl":"10.12788/fp.0603","url":null,"abstract":"<p><strong>Background: </strong>Recent phase 2 randomized clinical trials support the use of aggressive local treatment in addition to systemic therapy for oligometastatic disease (OMD) to improve progression-free survival and overall survival. These studies have mostly incorporated stereotactic body radiotherapy and serve as the foundation for multiple phase 3 trials aiming to determine how many metastases comprehensive local radiotherapy (RT) offer survival benefits, and for which cancers.</p><p><strong>Methods: </strong>To understand clinician views on the role of local RT for OMD, a 12-question survey was developed that included case examples. The survey was distributed to Veterans Health Administration (VHA) radiation oncologists and medical oncologists.</p><p><strong>Results: </strong>Of 106 survey respondents, 59 (55.7%) were radiation oncologists and 47 (44.3%) were medical oncologists. All respondents indicated high-dose RT has potential benefits for appropriately selected cases. Most oncologists (88.7%) responded that RT for OMD contributes to cure (88.1% radiation oncologists, 89.4% medical oncologists; <i>P</i> = .84). More than half (52.9%) of respondents (55.2% radiation oncologists, 50.0% medical oncologists; <i>P</i> = .60) indicated that local RT for OMD should not be limited by histology. Most radiation oncologists classified ≤ 5 lesions as OMD, whereas most medical oncologists classified ≤ 3 lesions as OMD (<i>P</i> = .006). Thirty-six medical oncologists (76.6%) has a radiation oncology department at their institution. This subgroup was more likely to consider local RT as potentially curative than peers without radiation oncology at their institution (94.4% vs 72.7%; <i>P</i> = .04). Management differences in the 3 oligometastatic cases were also identified.</p><p><strong>Conclusions: </strong>The results of this study highlight ongoing support among VHA oncologists for local RT in the management of OMD and reveal specialty-based and access-based variability in treatment perspectives.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 Suppl3","pages":"S3-S8"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494332/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Subcutaneous Contraception for Patient Self-Administration at North Florida/South Georgia Veterans Health System. 北佛罗里达/南乔治亚退伍军人健康系统中皮下避孕对患者自我管理的评价。
Pub Date : 2025-08-01 Epub Date: 2025-08-15 DOI: 10.12788/fp.0614
Jalaina M Brown, Kristyn M Pardo

Background: Depot medroxyprogesterone acetate (DMPA) is an injectable progestin-only contraceptive available in intramuscular and subcutaneous formulations. Initially, DMPA required administration by a health care professional. The World Health Organization now recommends patients be offered the option to self-administer injectable contraception using the subcutaneous form of DMPA (DMPA-SC). Self-administered DMPA-SC removes barriers to administration, increases patient autonomy, and improves contraceptive continuation rates.

Observations: This medication use evaluation assessed the impact of an initiative at North Florida/South Georgia Veterans Health System (NFSGVHS) to offer patients self-administered DMPA-SC. A retrospective chart review of electronic health records was conducted for patients who received ≥ 1 outpatient prescription for DMPA-SC from June 1, 2022, to July 1, 2023. Forty patients initiated self-administered DMPA-SC. A subgroup of patients were contacted via telephone as a follow-up to determine if there were unmet needs for ongoing contraceptive care.

Conclusions: The uptake in prescribing suggests that clinicians and patients have embraced self-administration of DMPA-SC within the NFSGVHS.

背景:醋酸甲孕酮(DMPA)是一种可注射的单孕激素避孕药,可用于肌肉注射和皮下注射。最初,DMPA需要由卫生保健专业人员管理。世界卫生组织现在建议患者可以选择使用皮下形式的DMPA (DMPA- sc)自行注射避孕。自我给药的DMPA-SC消除了给药的障碍,增加了患者的自主性,并提高了避孕的延续率。观察:该药物使用评估评估了北佛罗里达/南乔治亚退伍军人健康系统(NFSGVHS)为患者提供自我管理DMPA-SC的倡议的影响。对2022年6月1日至2023年7月1日期间接受DMPA-SC门诊处方≥1次的患者进行电子健康记录回顾性分析。40例患者开始自我给药DMPA-SC。通过电话联系一组患者作为随访,以确定是否存在未满足持续避孕护理需求的情况。结论:处方中的吸收表明临床医生和患者已经接受了NFSGVHS中DMPA-SC的自我管理。
{"title":"Evaluation of Subcutaneous Contraception for Patient Self-Administration at North Florida/South Georgia Veterans Health System.","authors":"Jalaina M Brown, Kristyn M Pardo","doi":"10.12788/fp.0614","DOIUrl":"10.12788/fp.0614","url":null,"abstract":"<p><strong>Background: </strong>Depot medroxyprogesterone acetate (DMPA) is an injectable progestin-only contraceptive available in intramuscular and subcutaneous formulations. Initially, DMPA required administration by a health care professional. The World Health Organization now recommends patients be offered the option to self-administer injectable contraception using the subcutaneous form of DMPA (DMPA-SC). Self-administered DMPA-SC removes barriers to administration, increases patient autonomy, and improves contraceptive continuation rates.</p><p><strong>Observations: </strong>This medication use evaluation assessed the impact of an initiative at North Florida/South Georgia Veterans Health System (NFSGVHS) to offer patients self-administered DMPA-SC. A retrospective chart review of electronic health records was conducted for patients who received ≥ 1 outpatient prescription for DMPA-SC from June 1, 2022, to July 1, 2023. Forty patients initiated self-administered DMPA-SC. A subgroup of patients were contacted via telephone as a follow-up to determine if there were unmet needs for ongoing contraceptive care.</p><p><strong>Conclusions: </strong>The uptake in prescribing suggests that clinicians and patients have embraced self-administration of DMPA-SC within the NFSGVHS.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"314-317"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profound Hypoxemia in a Patient With Hypertriglyceridemia-Induced Pancreatitis. 高甘油三酯血症诱发的胰腺炎患者的深度低氧血症。
Pub Date : 2025-08-01 Epub Date: 2025-08-16 DOI: 10.12788/fp.0610
Eileen Nguyen, Jeffrey Xia, Jennifer S Kim, Melisa R Chang, Jaime Betancourt, Dale Jun

Background: Acute lung injury and acute respiratory distress syndrome are potentially fatal complications of severe acute pancreatitis. In some cases, respiratory failure in acute pancreatitis is associated with negative radiographic findings. Hypertriglyceridemia is a known precipitant of acute pancreatitis; however, whether the severity of the hypertriglyceridemia can accurately predict the severity of the hypoxemia in acute pancreatitis remains unclear.

Case presentation: A male with morbid obesity and untreated sleep apnea presented with hypoxemia in the setting of severe hypertriglyceridemia, but with negative chest imaging. The severity of the patient's respiratory dysfunction coincided with elevations in his serum triglycerides.

Conclusions: This case demonstrates the complex relationship between hypertriglyceridemia, inflammation, and pulmonary dysfunction.

背景:急性肺损伤和急性呼吸窘迫综合征是严重急性胰腺炎的潜在致命并发症。在某些情况下,急性胰腺炎的呼吸衰竭与阴性影像学表现有关。高甘油三酯血症是已知的急性胰腺炎的前兆;然而,高甘油三酯血症的严重程度能否准确预测急性胰腺炎低氧血症的严重程度尚不清楚。病例介绍:一名患有病态肥胖和未经治疗的睡眠呼吸暂停的男性,在严重高甘油三酯血症的背景下表现为低氧血症,但胸部影像学呈阴性。患者呼吸功能障碍的严重程度与血清甘油三酯升高一致。结论:本病例显示了高甘油三酯血症、炎症和肺功能障碍之间的复杂关系。
{"title":"Profound Hypoxemia in a Patient With Hypertriglyceridemia-Induced Pancreatitis.","authors":"Eileen Nguyen, Jeffrey Xia, Jennifer S Kim, Melisa R Chang, Jaime Betancourt, Dale Jun","doi":"10.12788/fp.0610","DOIUrl":"10.12788/fp.0610","url":null,"abstract":"<p><strong>Background: </strong>Acute lung injury and acute respiratory distress syndrome are potentially fatal complications of severe acute pancreatitis. In some cases, respiratory failure in acute pancreatitis is associated with negative radiographic findings. Hypertriglyceridemia is a known precipitant of acute pancreatitis; however, whether the severity of the hypertriglyceridemia can accurately predict the severity of the hypoxemia in acute pancreatitis remains unclear.</p><p><strong>Case presentation: </strong>A male with morbid obesity and untreated sleep apnea presented with hypoxemia in the setting of severe hypertriglyceridemia, but with negative chest imaging. The severity of the patient's respiratory dysfunction coincided with elevations in his serum triglycerides.</p><p><strong>Conclusions: </strong>This case demonstrates the complex relationship between hypertriglyceridemia, inflammation, and pulmonary dysfunction.</p>","PeriodicalId":94009,"journal":{"name":"Federal practitioner : for the health care professionals of the VA, DoD, and PHS","volume":"42 8","pages":"304-307"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Federal practitioner : for the health care professionals of the VA, DoD, and PHS
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1